InDex Pharmaceuticals Holding AB announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate for treating moderate to severe ulcerative colitis.
from Medindia Health News https://ift.tt/3a2Uu8a
No comments:
Post a Comment